Literature DB >> 12388239

Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice.

Esther E J M Creemers1, Jeniffer N Davis, Andrea M Parkhurst, Peter Leenders, Kathryn B Dowdy, Elizabeth Hapke, Anne M Hauet, Patricia G Escobar, Jack P M Cleutjens, Jos F M Smits, Mat J A P Daemen, Michael R Zile, Francis G Spinale.   

Abstract

Recent studies have been directed at modulating the heart failure process through inhibition of activated matrix metalloproteinases (MMPs). We hypothesized that a loss of MMP inhibitory control by tissue inhibitor of MMP (TIMP)-1 deficiency alters the course of postinfarction chamber remodeling and induced chronic myocardial infarction (MI) in wild-type (WT) and TIMP-1(-/-) mice. Left ventricular (LV) pressure-volume loops obtained from WT and TIMP-1(-/-) mice demonstrated that LV end-diastolic volume [52 +/- 4 (WT) vs. 71 +/- 6 (TIMP-1(-/-)) microl] and LV end-diastolic pressure [9.0 +/- 1.2 (WT) vs. 12.7 +/- 1.4 (TIMP-1(-/-)) mmHg] were significantly increased in the TIMP-1(-/-) mice 2 wk after MI. LV contractility was reduced to a similar degree in the WT and TIMP-1(-/-) groups after MI, as indicated by a significant fall in the LV end-systolic pressure-volume relationship. Ventricular weight and cross-sectional areas of LV myocytes were significantly increased in TIMP-1(-/-) mice, indicating that the hypertrophic response was more pronounced. The observed significant loss of fibrillar collagen in the TIMP-1(-/-) controls may have been an important contributory factor for the observed LV alterations in the TIMP-1(-/-) mice after MI. These findings demonstrate that TIMP-1 deficiency amplifies adverse LV remodeling after MI in mice and emphasizes the importance of local endogenous control of cardiac MMP activity by TIMP-1.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2002        PMID: 12388239     DOI: 10.1152/ajpheart.00511.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  67 in total

Review 1.  Clinical implications of matrix metalloproteinases.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Chakraborti Sajal
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

2.  Tipping the extracellular matrix balance during heart failure progression: do we always go right?

Authors:  Ying Ann Chiao; Yu-Fang Jin; Merry L Lindsey
Journal:  Cardiology       Date:  2010-07-02       Impact factor: 1.869

Review 3.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 4.  Imaging of matrix metalloproteinase activation and left ventricular remodeling.

Authors:  Grace Chung; Albert J Sinusas
Journal:  Curr Cardiol Rep       Date:  2007-04       Impact factor: 2.931

Review 5.  Progress in matrix metalloproteinase research.

Authors:  Gillian Murphy; Hideaki Nagase
Journal:  Mol Aspects Med       Date:  2008-05-24

6.  Short-term disruption in regional left ventricular electrical conduction patterns increases interstitial matrix metalloproteinase activity.

Authors:  Rupak Mukherjee; Juozas A Zavadzkas; William T Rivers; Julie E McLean; Eileen I Chang; Shenikqua Bouges; Robert G Matthews; Christine N Koval; Robert E Stroud; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-05-14       Impact factor: 4.733

7.  Tissue inhibitor of metalloproteinase-1 and -3 improves cardiac function in an ischemic cardiomyopathy model rat.

Authors:  Ayako Uchinaka; Naomasa Kawaguchi; Seiji Mori; Yoshinosuke Hamada; Shigeru Miyagawa; Atsuhiro Saito; Yoshiki Sawa; Nariaki Matsuura
Journal:  Tissue Eng Part A       Date:  2014-06-16       Impact factor: 3.845

8.  Effects of exercise training on cardiac function and myocardial remodeling in post myocardial infarction rats.

Authors:  Xiaohua Xu; Wenhan Wan; Anthony S Powers; Ji Li; Lisa L Ji; Shunhua Lao; Bryan Wilson; John M Erikson; John Q Zhang
Journal:  J Mol Cell Cardiol       Date:  2007-10-12       Impact factor: 5.000

Review 9.  Intramyocardial fibroblast myocyte communication.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Circ Res       Date:  2010-01-08       Impact factor: 17.367

10.  Lipopolysaccharide upregulates uPA, MMP-2 and MMP-9 via ERK1/2 signaling in H9c2 cardiomyoblast cells.

Authors:  Yi-Chang Cheng; Li-Mien Chen; Mu-Hsin Chang; Wei-Kung Chen; Fuu-Jen Tsai; Chang-Hai Tsai; Tung-Yuan Lai; Wei-Wen Kuo; Chih-Yang Huang; Chung-Jung Liu
Journal:  Mol Cell Biochem       Date:  2009-01-28       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.